Patent · US Active

Genetically engineered microbial strains including Prototheca lipid pathway genes

US9328351B2 · kind B2 · utility

14Cited by

8References

13Claims

0Family size

Assignee

SOLAZYME, INC. · US

Inventors

Scott Franklin · South San Francisco, US
Shane Brubaker · Corona, US
George Rudenko · Mountain View, US
Jeffrey L. Moseley · Redwood City, US
Xinhua Zhao · Foster City, US
Tina HUYNH · Oakland, US
Riyaz Bhat · Fremont, US
Matthew Shoa-Azar · San Mateo, US
Trung H. Nguyen · San Jose, US
Karen Espina · San Francisco, US
Aravind Somanchi · Redwood City, US

Key dates

Filing date	Nov 28, 2012
Grant date	May 3, 2016
Priority date	—
Expiry date	Jul 3, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/52
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Genetically engineered microbial, e.g., Prototheca, cells provide microbial oil useful as a food additive and a source of renewable fuels and industrial chemicals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.